Novo Nordisk says it is rebranding to Novo and updating its corporate culture as it seeks to regain obesity drug market share and prepare for a strategy update at its Sept. 21 Capital Markets Day.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0